true
Icon to close the modal
Support
Sales
Phone Icon
1.844.8.BD.LIFE (1.844.823.5433)
Modal Close Icon

Capability:

Product Line:

Icon to close thank you modal
Thank you for contacting our sales team!
A sales representive will get in touch with you shortly.
Customer Service
Phone Icon
1.844.8.BD.LIFE (1.844.823.5433)
Fax Icon
1.800.847.2220

BD MaxPlus™ Extension Sets

Choose the only needle-free connector with an FDA-cleared label statement demonstrating a reduction in CLABSI¹

Contact Us
maxplus-extension-sets_banner_VA_0517-1107
maxplus-maxzero-extension-sets_RC_IV_0609_0174.png
maxplus-extensions-sets_C_IV_VA_0517-1188.png
Loading
Overview

Hospitals using the BD MaxPlus™ needle-free connector had lower unadjusted central line-associated bloodstream infection (CLABSI) rates, as well as lower standardised infection ratios, compared to hospitals not using the MaxPlus technology.*2

true
Features and Benefits

Solid sealed surface

The solid sealed surface withstands 7 days/200 activations.

Clear housing

The clear design shows the complete fluid pathway, enabling optimal visibility when flushing.

No interstitial space

Zero interstitial space between the components limits opportunities for microbial ingress.

Zero-reflux action

Zero-reflux feature upon disconnection can help reduce catheter occlusions and costly restarts.

References

Please note, not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.

* 2013 CMS hospital compare data from 3,074 hospitals, accounting for nearly 11,000 CLABSIs associated with nearly 10 million catheter days

References
  1. Data on File: REF-3786 - PS100009 and PS100010 / 510(k) Number: K051939 and K072542 (6 Aug 2014)
  2. Tabak YP, Johannes RS, Sun X, Crosby CT, Jarvis WR. Innovative use of existing public and private data sources for postmarket surveillance of central line-associated bloodstream infections associated with intravenous needleless connectors. J Infus Nurs. 2016;39(5):328-335.

BD-39472 (08/2021)

true